Near to Infrared (NIR) Light Neuroprotection in Glaucomatous Optic Neuropathy
Primary Purpose
Open Angle Glaucoma
Status
Unknown status
Phase
Early Phase 1
Locations
Chile
Study Type
Interventional
Intervention
Near to infrared light retinal stimulation
Green light stimulation
Sponsored by
About this trial
This is an interventional treatment trial for Open Angle Glaucoma focused on measuring Open Angle Glaucoma, Biophotomodulation, Near to Infrared light stimulation, Neuroprotection
Eligibility Criteria
Inclusion Criteria:
- Clinical diagnose of Ocular Hypertension (cup to disk ratio 0,6 or less, normal Humphrey 24-2 visual field with aplanatic IOP over 21 mmHg) or Mild Glaucoma (cup to disk ratio 0,6 to 0,8, characteristic Humphrey 24-2 visual field defect PSD between 3 and 6 dB).
- Visual acuity 20/40 or better
Exclusion Criteria:
- Diabetic retinopathy, Multiple Sclerosis, Parkinson disease
- Refractive error of 3 diopters or more
Sites / Locations
- Servicio de Oftalmología Hospital Van Buren
Arms of the Study
Arm 1
Arm 2
Arm Type
Active Comparator
Placebo Comparator
Arm Label
NIR light
Green light
Arm Description
Group of patients stimulated with near to infrared light daily stimulation
Group of patients stimulated with green light.
Outcomes
Primary Outcome Measures
Pattern electroretinogram response
Secondary Outcome Measures
OCT ganglion cell layer average thickness, Visual Field defects
Full Information
NCT ID
NCT00844389
First Posted
February 13, 2009
Last Updated
September 30, 2009
Sponsor
Universidad de Valparaiso
Collaborators
Comisión Nacional de Investigación Científica y Tecnológica
1. Study Identification
Unique Protocol Identification Number
NCT00844389
Brief Title
Near to Infrared (NIR) Light Neuroprotection in Glaucomatous Optic Neuropathy
Official Title
Near to Infrared Light Stimulation Effect on Ganglion Cell Function in Glaucomatous Optic Neuropathy
Study Type
Interventional
2. Study Status
Record Verification Date
September 2009
Overall Recruitment Status
Unknown status
Study Start Date
April 2009 (undefined)
Primary Completion Date
December 2009 (Anticipated)
Study Completion Date
March 2010 (Anticipated)
3. Sponsor/Collaborators
Name of the Sponsor
Universidad de Valparaiso
Collaborators
Comisión Nacional de Investigación Científica y Tecnológica
4. Oversight
Data Monitoring Committee
No
5. Study Description
Brief Summary
The purpose of the study is to evaluate if near-to-infrared light stimulation can improve retinal ganglion cell function in glaucomatous patients.
Detailed Description
Ganglion cell dysfunction in glaucomatous optic neuropathy has been ascribed to ganglion cell electrophysiological inactivation and to apoptotic cell death. Near-to-infrared light stimulation has been used to induce mitochondrial activation and to prevent apoptotic death through mitochondrial cytochrome oxidase c stimulation. Near-to-infrared light stimulation might be useful to induce ganglion cell activation and inhibit apoptotic cell death.
We propose that near-to-infrared light stimulation can be used as an adjuvant treatment combined with ocular hypotensive treatment in glaucomatous patients.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Open Angle Glaucoma
Keywords
Open Angle Glaucoma, Biophotomodulation, Near to Infrared light stimulation, Neuroprotection
7. Study Design
Primary Purpose
Treatment
Study Phase
Early Phase 1
Interventional Study Model
Parallel Assignment
Masking
ParticipantInvestigator
Allocation
Randomized
Enrollment
40 (Anticipated)
8. Arms, Groups, and Interventions
Arm Title
NIR light
Arm Type
Active Comparator
Arm Description
Group of patients stimulated with near to infrared light daily stimulation
Arm Title
Green light
Arm Type
Placebo Comparator
Arm Description
Group of patients stimulated with green light.
Intervention Type
Device
Intervention Name(s)
Near to infrared light retinal stimulation
Intervention Description
Patients will be stimulated with 660 nm light frequency through a LED device. Patients will be stimulated daily for two minutes for a 6 month period.
Intervention Type
Device
Intervention Name(s)
Green light stimulation
Intervention Description
Patients will be stimulated with 530 nm LED light frequency through a LED device. Patients will be stimulated daily for two minutes for a 6 month period.
Primary Outcome Measure Information:
Title
Pattern electroretinogram response
Time Frame
Every two weeks for 4 months
Secondary Outcome Measure Information:
Title
OCT ganglion cell layer average thickness, Visual Field defects
Time Frame
Every month for four months
10. Eligibility
Sex
All
Minimum Age & Unit of Time
40 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
Clinical diagnose of Ocular Hypertension (cup to disk ratio 0,6 or less, normal Humphrey 24-2 visual field with aplanatic IOP over 21 mmHg) or Mild Glaucoma (cup to disk ratio 0,6 to 0,8, characteristic Humphrey 24-2 visual field defect PSD between 3 and 6 dB).
Visual acuity 20/40 or better
Exclusion Criteria:
Diabetic retinopathy, Multiple Sclerosis, Parkinson disease
Refractive error of 3 diopters or more
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Tatiana E Cevo, M.D
Organizational Affiliation
Universidad de Valparaiso
Official's Role
Principal Investigator
First Name & Middle Initial & Last Name & Degree
Adrian Palacios, PhD
Organizational Affiliation
Universidad de Valparaiso
Official's Role
Study Director
Facility Information:
Facility Name
Servicio de Oftalmología Hospital Van Buren
City
Valparaiso
Country
Chile
12. IPD Sharing Statement
Learn more about this trial
Near to Infrared (NIR) Light Neuroprotection in Glaucomatous Optic Neuropathy
We'll reach out to this number within 24 hrs